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Although microRNAs (miRNAs) have been intensively studied in cardiac fibrosis, their roles in drug-mediated anti-fibrotic 
therapy are still unknown. Previously, Pioglitazone attenuated cardiac fibrosis and increased miR-711 experimentally. We 
aimed to explore the role and mechanism of miR-711 in pioglitazone-treated myocardial infarction in rats. Our results showed 
that pioglitazone significantly reduced collagen-I levels and increased miR-711 expression in myocardial infarction heart. 
Pioglitazone increased the expression of miR-711 in cardiac fibroblasts, and overexpression of miR-711 suppressed collagen-I 
levels in angiotensin II (Ang II)-treated or untreated cells. Transfection with antagomir-711 correspondingly abolished the 
pioglitazone-induced reduction in collagen-I levels. Bioinformatics analysis identified SP1, which directly promotes collagen-I 
synthesis, as the putative target of miR-711. This was confirmed by luciferase assay and western blot analysis. Additionally, 
increased SP1 expression was attenuated by pioglitazone in myocardial infarction heart. Furthermore, transfection of antago-
mir-711 attenuated pioglitazone-reduced SP1 expression in cardiac fibroblasts with or without Ang II stimulation. We    
conclude that pioglitazone up-regulated miR-711 to reduce collagen-I levels in rats with myocardial infarction. The 
miR-711-SP1-collagen-I pathway may be involved in the anti-fibrotic effects of pioglitazone. Our findings may provide new 
strategies for miRNA-based anti-fibrotic drug research. 
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Interstitial fibrosis is a major aspect of myocardial remod-
eling following myocardial infarction (MI), which contrib-
utes to impaired cardiac contractility and loss of pump func-
tion [1]. The extracellular matrix (ECM), which mainly in-
cludes collagen deposition, contributes to adverse cardiac 
interstitial fibrosis after MI. Therefore, inhibiting the pro-
cess of collagen synthesis may be clinically relevant for the 
prevention and treatment of heart failure after MI. Since 
specific anti-fibrotic agents are not currently available, con-
siderable efforts have focused on exploring new therapeutic 
signaling pathways that can attenuate adverse cardiac fibro-
sis.  
Pioglitazone is an insulin-sensitizing drug that acts as a 
high affinity ligand for PPARγ, and has a cardiac protective 
role in various cardiovascular diseases [2,3]. It attenuated 
cardiac fibrosis, improved left ventricular failure and re-
duced myocardial infarct size after experimental MI [4–6]. 
Anita et al. [7] observed that inhibiting PPARγ com-
pletely abolished the up-regulation of miR-711 expression 
in mouse adipose cells. In addition, the expression levels of 
miR-711 were markedly changed in myocardial infarction 
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[8]. Thus, we suggest that miR-711 may play a role in 
pioglitazone- mediated anti-fibrotic processes in myocardial 
infarction.  
In the present study, we aimed to investigate whether 
miR-711 was altered by pioglitazone treatment in MI and its 
potential signaling pathway. 
1  Methods 
All experimental procedures were performed in accordance 
with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH 
publication, 8th edition, 2011), and the Guidelines for Ani-
mal Experiments, Peking University Health Science Center. 
1.1  Animal model preparation 
All surgical procedures were performed with male Sprague-   
Dawley (SD) rats (eight weeks old, 180–200 g) anaesthe-
tized with sodium pentobarbital (50 mg kg1 intraperitone-
ally). Experimental MI was induced by ligation of the left 
anterior descending coronary artery as previously described 
[9]. Control rats were treated in the same way without liga-
tion (sham operation). Rats were randomly subdivided into 
four groups for treatment: (i) vehicle+sham (n=6): water and 
sham operation; (ii) pioglitazone+sham (n=6): pioglitazone 
and sham operation; (iii) vehicle+MI (n=8): water and MI; 
and (iv) pioglitazone+MI (n=8): pioglitazone and MI. All 
rats were administered pioglitazone (Takeda Pharmaceuti-
cals, Osaka, Japan; 10 mg kg1 d1) or water each day for 
four weeks via gastro-gavage and underwent surgery at the 
end of week 2. Hearts were removed at two weeks after 
surgery. The walls of ventricles were fixed with 4% (w/v) 
paraformaldehyde and the remaining samples were stored in 
liquid nitrogen. 
1.2  Histology 
Heart ventricles were fixed with 4% (w/v) paraformalde-
hyde, dehydrated, and embedded in paraffin. Ventricle sec-
tions were stained with Sirius red to observe interstitial fi-
brosis. To determine the degree of cardiac fibrosis, the car-
diac collagen volume fraction was calculated as the ratio of 
Sirius red-stained fibrosis area to total myocardium area 
with the use of Image-Pro Plus 6.0. 
1.3  Quantitative real-time PCR 
Total RNA was extracted by Trizol Reagent method (Invi-
trogen, Carlsbad, CA, USA). Relative quantification by 
real-time PCR involved SYBR-green detection of PCR 
products in real time with the ABI PRISM 7700 Sequence 
Detection System (Applied Biosystems, Invitrogen). Rat 
18s ribosomal RNA was amplified as a reference standard. 
Reactions were prepared in triplicate and heated to 95°C for 
5 min, followed by 40 cycles at 94°C for 30 s, 60°C for 30 s, 
and 72°C for 30 s. 
Small RNA was isolated using the miRcute miRNA iso-
lation kit (Tiangen Biotech, Beijing, China). The miRcute 
microRNA first-strand cDNA synthesis and qPCR detection 
kits (Tiangen) were used for miRNA analysis. Quantitative 
PCR was performed using the ABI PRISM 7700 Sequence 
Detection System. Rat 5s ribosomal RNA was used as an 
internal control. The primer sequences are shown in Table 
S1. 
1.4  Cell culture, transfection and luciferase assay 
Cardiac fibroblasts were isolated as previously described 
[10], grown to 80% confluence and serum starved for 24 h 
in serum-free medium before treatment with angiotensin II 
(0.1 mol) or being transfected with agomir (100 nmol; 
RibioBio, Guangzhou, China) or antagomir (50 nmol; 
RibioBio). HEK293 cells were transfected with plasmid 
DNA (PGL3-SP1-3′UTR/PGL3-SP1-3′UTR deletion 200 ng, 
RTK 20 ng) and miRNA mimics (5 nmol; RibioBio) using 
Lipofectamine 2000 according to the manufacturer’s meth-
ods (Invitrogen). Luciferase activity was measured by the 
Dual-Luciferase Reporter Assay System (Promega, Madi-
son, WI, USA). 
1.5  Western blot analysis  
Total protein was extracted by RIPA buffer (CxBio, 
Shanghai, China) supplemented with phenylmethanesul-
fonyl (PMSF, CxBio). Protein concentrations were meas-
ured by the BCA Protein Assay (Applygen, Beijing, China). 
The samples were separated on 10% SDS-polyacrylamide 
gel and then transferred to a nitrocellulose membrane 
blocked in 5% skim milk for 1 h and then incubated with 
anti-SP1 and eIF5 antibodies (both Santa Cruz Biotechnology, 
CA, USA) at 4°C overnight. After washing, membranes were 
incubated with horseradish peroxidase-labeled secondary 
antibodies for 1 h at room temperature. Bands were visual-
ized using a chemiluminescence detection system. Autora-
diographs were quantified by densitometry (Science Imag-
ing System, Bio-Rad, USA). EIF5 levels were used as in-
ternal controls for protein normalization. 
1.6  Enzyme-linked immunosorbent assay (ELISA) 
Collagen-I was analyzed in proteins from heart tissue and 
cardiac fibroblasts by a rat collagen-I ELISA kit (Cat. No. 
CK-E30413; Qxbio, Beijing, China). Heart tissues were 
prepared with lysis buffer (10 mmol L1 Tris pH 7.4, 0.1 
mol L1 NaCl, 1 mmol L1 EDTA, 1 mmol L1 EGTA, 1 
mmol L1 NaF, 20 mmol L1 Na4P2O7, 2 mmol L1 Na3VO4, 
0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 
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10% glycerol) with the addition of PMSF (1 mmol L1) and 
aprotinin (1 g mL1). Cells were lysed by pipetting in 
complete cell extraction buffer (Cat. No. FNN0011, Invi-
trogen) with the addition of PMSF (1 mmol L1) and prote-
ase cocktail (50 L mL1) (Cat. No. P-2714; Sigma, St. 
Louis, MO, USA). Collagen-I protein content was normal-
ized to that of total protein. 
1.7  Bioinformatics analyses 
We used TargetScan (http://www.targetscan.org) and PITA 
(http://genie.weizma-nn.ac.il/pubs/mir07/mir07data.html)  
for miRNA target gene prediction. 
1.8  Statistical analysis 
Results are presented as mean±standard error of the mean 
(SEM). One-way ANOVA or two-way ANOVA with a 
Bonferroni post-hoc test was used as applicable. P<0.05 
was considered statistically significant. 
2  Results 
2.1  Pioglitazone attenuated cardiac fibrosis after MI in 
vivo 
Rat heart sections were stained with Sirius red to examine 
collagen levels (Figure 1A). Collagen deposition appeared 
to increase following MI but was attenuated with pioglita-
zone treatment. Interstitial fibrosis assessed by collagen 
volume fraction was markedly reduced by 75% following 
pioglitazone treatment compared with control treatment, 
with no significant difference in sham-operated hearts (Fig-
ure 1B). In MI hearts, the relative protein content of myo-
cardial collagen-I was significantly increased compared 
with sham-treated hearts but decreased by 38% compared 
with the pioglitazone-treated group (Figure 1C). 
2.2  Effect of pioglitazone on miR-711 expression  
The miR-711 expression profile following MI detected by 
real-time PCR is shown in Figure S1. 
MiR-711 levels were significantly down-regulated by 
80% in MI rats with vehicle treatment (P<0.001), and the 
down-regulation was significantly inhibited by pioglitazone 
treatment (P<0.05) (Figure 2A). 
To confirm the direct effects of pioglitazone on miR-711, 
a dose-response experiment was performed in neonatal rat 
cardiac fibroblasts. The results showed that miR-711 was 
up-regulated dose-dependently with pioglitazone (1–10 
µmol) for 24 h (Figure 2B). 
We further evaluated the effect of pioglitazone on 
miR-711 levels in Ang II-stimulated cardiac fibroblasts. 
MiR-711 expression was not affected by Ang II treatment  
 
Figure 1  Effect of pioglitazone on cardiac fibrosis induced by myocardi-
al infarction (MI) in rats. A, Representative micrographs of Sirius red 
staining of heart sections from MI and sham-operated groups (400×). B, 
Interstitial collagen volume fraction (CVF) in Sirius red-stained 
cross-sections of heart ventricles (n=6). C, ELISA of collagen-I expression 
(n=6–8). Data are mean±SEM. ***, P<0.001 vs. vehicle+sham; ###, 
P<0.001 vs. vehicle+MI. 
 
(Figure S2), but miR-711 was up-regulated after pre-treat-      
ment with pioglitazone (10 µmol) for 1 h and Ang II (0.1 
mol) for up to 24 h (Figure 2C). 
2.3  MiR-711 participated in pioglitazone-induced inhi-
bition of collagen-I expression 
To detect the effects of miR-711 on collagen-I levels, car-
diac fibroblasts were transfected with agomir-711, antago-
mir-711 or nothing for the negative control (NC). The 
overexpression of agomir-711 and antagomir-711 was iden-
tified by quantification of miR-711 levels (Figure S3). Col-
lagen-I protein levels were significantly down-regulated by 
agomir-711 (Figure 3A) and up-regulated by antagomir-711 
treatment (Figure 3B) compared with NC. To determine 
whether pioglitazone inhibited collagen-I protein expression 
via miR-711, cardiac fibroblasts were incubated with 
pioglitazone after transfection of antagomir-711. The down-      
regulation of collagen-I after pioglitazone treatment was 
attenuated by antagomir-711 transfection (Figure 3C). 
434 Zhao N, et al.   Sci China Life Sci   May (2013) Vol.56 No.5 
 
Figure 2  Effect of pioglitazone on miR-711 expression in rat myocardial 
tissue and neonatal rat cardiac fibroblasts. A, Real-time PCR analysis of 
miR-711 (n=6–8). Expression of miR-711 was standardized to 5s riboso-
mal RNA level. Data are mean±SEM. ***, P<0.001 vs. vehicle+sham; ##, 
P<0.01 vs. vehicle+MI. B, Cells were treated with pioglitazone (1, 5 and 
10 mol) for 24 h and then miR-711 expression was detected (n=3) (con-
trol was treated with DMSO). ***, P<0.001 vs. control. C, Cells were 
pre-incubated with pioglitazone (10 mol) for 1 h, treated with angiotensin 
II (Ang II) (0.1 mol) for up to 24 h, then miR-711 expression was detect-
ed (n=3). ***, P<0.001 vs. control; ###, P<0.001 vs. Ang II. 
In addition, collagen-I expression was increased ap-
proximately 1.6- to 1.9-fold in Ang II-stimulated cardiac 
fibroblasts compared with controls (P<0.001). Agomir-711 
inhibited increased collagen-I expression by about 31% 
(P<0.001) (Figure 3D). We transfected cardiac fibroblasts 
with antagomir-711 to antagonize pioglitazone-induced 
miR-711 levels by Ang II stimulation. Collagen-I expres-
sion was increased compared with Ang II and pioglitazone 
treatment (P<0.001) (Figure 3E). 
2.4  Downstream signaling of miR-711 
To explore the underlying mechanism of miR-711 mediated 
down-regulation of collagen-I content, we used bioinfor-
matics analysis to predict the potential targets of miR-711 
(Table S2). We revealed one predicted binding site of 
miR-711 within the 3′ untranslated region of SP1, which 
promotes collagen-I synthesis in tissue fibrosis. The comple-
mentary nucleotides between the miR-711 seed sequences 
and the SP1 binding site were highly conserved among spe-
cies, including humans, rats and mice (Figure 4A).  
To confirm that SP1 is the direct target of miR-711, we 
transfected HEK293 cells with a luciferase reporter plasmid 
pGL3-SP1-3′UTR or control scramble target sites (pGL3-   
SP1-deletion) for sequence specificity. Luciferase activity 
of the pGL3-SP1-3′UTR reporter was significantly sup-
pressed in cells transfected with miRNA mimic-711 com-
pared with NC normalized to a control vector containing 
Renilla luciferase, pRL-TK. Transfection with the pGL3- 
SP1-deletion reporter abolished this effect (Figure 4B). 
To examine further whether miR-711 regulated SP1 ex-
pression, cardiac fibroblasts were transfected with agomir 
and antagomir. The protein levels of SP1 were significantly 
decreased with miR-711 overexpression and significantly 
increased with miR-711 inhibition (Figure 4C). However, 
mRNA levels were not significantly changed by miR-711 
treatment (Figure 4D). 
2.5  Pioglitazone inhibited SP1 expression via miR-711 
in vivo and in vitro 
SP1 protein levels were significantly up-regulated in rats 
with MI compared with controls (P<0.001), and markedly 
reduced with pioglitazone treatment (31%, P<0.05) (Figure 
5A). 
Treatment with pioglitazone in cardiac fibroblasts for 24 h 
dose-dependently inhibited SP1 protein levels (Figure 5B). 
To determine whether pioglitazone inhibited SP1 protein 
expression via miR-711, cardiac fibroblasts were transfect-
ed with antagomir-711, then incubated with pioglitazone for 
24 h. SP1 protein expression was greater with pioglitazone 
and antagomir-711 than with pioglitazone alone (P<0.05) 
(Figure 5C).  
Overexpressing miR-711 with agomir inhibited increased 
SP1 protein levels compared with Ang II stimulation alone 
(P<0.01) (Figure 5D). In addition, the up-regulation of SP1 
protein expression with Ang II stimulation was attenuated 
by pioglitazone treatment (P<0.01) (Figure 5E). To deter-
mine whether miR-711 had an effect in the process, we used 
antagomir to antagonize miR-711, and the down-regulation 
of SP1 protein levels with Ang II and pioglitazone was at-
tenuated (P<0.001) (Figure 5F).  
3  Discussion 
Cardiac fibrosis is one of the leading causes of cardiac dys-
function in heart diseases. Pioglitazone has been reported to 
attenuate cardiac fibrosis and improve left ventricular fail-
ure [4–6]. The current study also demonstrated that 
pioglitazone inhibited collagen-I expression (Figure 1C) and  
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Figure 3  Pioglitazone inhibits collagen-I expression via miR-711 in cardiac fibroblasts. ELISA of collagen-I protein expression. Results are shown as a 
percentage of the control. A and B, Cardiac fibroblasts were transfected with agomir-711 and antagomir-711, collagen-I expression was detected (n=4). *, 
P<0.05 vs. control; #, P<0.05 vs. NC; ##, P<0.01 vs. NC. C, After transfection with antagomir-711, cardiac fibroblasts were incubated with pioglitazone (10 
µmol) for up to 48 h, then collagen-I expression was detected (n=4). *, P<0.05 vs. control; ##, P<0.01 vs. pioglitazone; $, P<0.05 vs. pioglita-
zone+antagomir-NC. D, After transfection with agomir-711, cells were stimulated with angiotensin II (Ang II) (0.1 mol) for up to 48 h, then collagen -I 
expression was detected (n=4). ***, P<0.001 vs. control; ###, P<0.001 vs. Ang II; $$$, P<0.001 vs. Ang II+agomir-negative control (NC). E, After transfec-
tion with antagomir-711 or NC, cells were pre-incubated with pioglitazone (10 µmol) for 1 h and then treated with Ang II (0.1 µmol) for up to 48 h, then 
collagen -I expression was detected (n=4). ***, P<0.001 vs. control; ##, P<0.01 vs. Ang II; ###, P<0.001 vs. Ang II; $, P<0.05 vs. Ang II+pioglitazone; ††, 
P<0.01 vs. Ang II+pioglitazone+antagomir-NC. 
 
ameliorated cardiac fibrosis in myocardial infarction hearts 
(Figure 1A and B). Additionally, our results showed that 
pioglitazone up-regulated endogenous miR-711 levels (Fig-
ure 2B and C), and attenuated down-regulation of miR-711 
in myocardial infarction hearts (Figure 2A). In addition, our 
results showed that down-regulation of collagen-I expres-
sion by pioglitazone in Ang II-treated cardiac fibroblasts 
was attenuated by transfection of antagomir-711 (Figure 
3E). These results demonstrate that pioglitazone reduced 
collagen-I expression via miR-711 in cardiac fibroblasts. 
Although the precise molecular mechanism of miR-711 
regulation by pioglitazone is unclear, miR-711 could be 
regulated by PPAR in mouse adipose cells [7]. We specu-
late that the anti-fibrotic effect of pioglitazone mediated by 
the miR-711 pathway occurs in a PPAR-dependent manner. 
A vast amount of data from recent years suggested that the 
anti-fibrotic effects of pioglitazone mediated by PPAR 
occur by various mechanisms, including control of inflam-
mation [11], cross-regulation of signaling events implicated 
in fibrogenesis [12–14], reducing oxidative stress-induced 
NAPDH oxidase-mediated ROS activity [13], and impact-
ing on the key molecules involved in both inflammation or  
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Figure 4  MiR-711 targeted by SP1. A, MiR-711 sequences and the binding site between miR-711 and SP1. B, HEK293 cells were co-transfected with 
PGL3-SP1-3′UTR and miRNA mimic-711/NC, PGL3-SP1-3′UTR-deletion and miRNA mimic-711/NC, for 48 h, then luciferase activity was detected 
(SP1-3′UTR, PGL3-luciferase plasmid containing the seed sequences of 3′UTR of SP1, SP1-3′UTR-deletion, PGL3-luciferase plasmid containing the deleted 
sequences/GGGUCC of 3′UTR of SP1) (n=4). ***, P<0.001 vs. SP1-3′UTR+Mimic-NC; ###, P<0.001 vs. SP1-3′UTR-deletion+Mimic-711. C and D, 
Western blot and real-time PCR analysis SP1 protein and mRNA expression, respectively, in cardiac fibroblasts transfected with agomir-711 and antago-
mir-711 (n=3). Expression of SP1 protein was standardized to eIF5 levels, and SP1 mRNA levels were standardized to that of 18s ribosomal RNA. ***, 
P<0.001 vs. control; ###, P<0.001 vs. NC; ##, P<0.01 vs. NC. 
fibrosis, such as, NF-B [15]. In light of these mechanisms, 
the effects of the pioglitazone-miR-711 pathway on in-
flammatory cells, fibrogenesis, molecular signaling and 
ROS require further exploration. It is worth noting that we 
observed binding sites between NF-B and the promoter of 
the host gene for miR-711 by bioinformatic analysis. Thus, 
we speculate the anti-fibrotic effects of pioglitazone medi-
ated by up-regulating miR-711 may be induced by the 
PPAR-NF-B pathway. This requires further elucidation. 
Previous studies indicated that PPAR activated by 
pioglitazone reduced SP1 protein expression [16], but the 
mechanisms involved were unclear. Our results (Figure 5B) 
suggest a possible mechanism where PPAR may down-     
regulate SP1 protein levels via miR-711. Ang II-induced 
SP1 expression has pro-fibrotic effects in cardiac fibroblasts 
[17], but does not affect the expression of miR-711 (Figure 
S2). Thus, Ang II stimulation was used to observe the effect 
of pioglitazone-induced up-regulation of miR-711. 
Recently, miR-711 levels were shown significantly 
changed after organs injury [8,18,19]. We also observed that 
miR-711 levels were down-regulated in rats with MI (Fig-
ure S1). Thus, miR-711 may play a key role in the process 
of cardiac fibrosis. Indeed, our results verify that miR-711 
regulated collagen-I expression in cardiac fibroblasts (Fig-
ure 3A, B and D), but whether the anti-fibrotic effects of 
pioglitazone was mediated by miR-711 in vivo requires fur-
ther study by inhibiting miR-711 with antagomir-711 in rats 
with MI. 
Emerging evidence has shown that miRNAs may regu-
late cardiac fibrosis by targeting many different mRNAs 
[20]. Analysis of the predicted targets of miR-711 (Table S2) 
demonstrated only SP1 as a key factor involved in the pro-
cess of fibrosis [21–23]. We identified SP1 protein as a tar-
get of miR-711 using luciferase assay and Western blot 
analysis (Figure 4B and C). SP1 protein is negatively regu-
lated by miR-711 in cardiac fibroblasts, and its mRNA ex-
pression is not altered by miR-711 (Figure 4D). Thus, 
miR-711 may negatively regulate SP1 expression at the  
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Figure 5  Pioglitazone inhibited SP1 expression via miR-711. Western blot analysis of SP-1 protein expression was standardized to eIF5 levels. A, Western 
blot analysis of SP1 protein expression in rat myocardium tissue (n=6). ***, P<0.001 vs. vehicle+sham; #, P<0.05 vs. vehicle+MI. B, Cardiac fibroblasts 
were treated with pioglitazone (1, 5 and 10 µmol) for 24 h, then SP1 expression was detected (n=4) (control was treated with DMSO). *, P<0.05 vs. control; 
**, P<0.01 vs. control. C, After transfection with antagomir-711, cardiac fibroblasts were incubated with pioglitazone (10 µmol) for up to 48 h, then SP1 
expression was detected (n=4). *, P<0.05 vs. control; **, P<0.01 vs. control; #, P<0.05 vs. pioglitazone; $$$, P<0.001 vs. pioglitazone+antagomir-NC. D, 
After transfection with agomir-711, cells were stimulated with Ang II (0.1 µmol) for up to 48 h, then SP1 expression was detected (n=4). ***, P<0.001 vs. 
control; ##, P<0.01 vs. Ang II; $$, P<0.01 vs. Ang II+agomir-NC. E, Cardiac fibroblasts were pre-treated with pioglitazone (10 µmol) for 1 h, treated with 
Ang II (0.1 µmol) for up to 48 h, then SP1 expression was detected (n=4). *, P<0.05 vs. control; **, P<0.01 vs. control; ##, P<0.01 vs. Ang II. F, After 
transfection of antagomir-711/NC, cells were pre-incubated with pioglitazone (10 µmol) for 1 h, treated with Ang II (0.1 µmol) for up to 48 h, then SP1 
expression was detected (n=4). ***, P<0.001 vs. control; #, P<0.05 vs. Ang II; $$$, P<0.001 vs. Ang II+pioglitazone; †††, P<0.001 vs. Ang 
II+pioglitazone+antagomir-NC. 
translational level in cardiac fibroblasts. Furthermore, our 
results showed pioglitazone inhibited SP1 protein expres-
sion in cardiac fibroblasts (Figure 5B and E), and the down-    
regulation of SP1 protein was attenuated by transfection of 
antagomir-711 (Figure 5D and F). This indicates that pio-       
glitazone inhibits collagen-I expression via miR-711-SP1.  
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Figure 6  Model for pioglitazone suppression of collagen-I expression via 
miR-711. 
In conclusion, the miR-711-SP1 pathway may be in-
volved in pioglitazone-mediated anti-fibrotic effects (Figure 
6), which may provide a new strategy for miRNA-based 
anti-fibrotic drug research. 
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Supporting Information 
Figure S1  The miR-711 expression profiles in cardiac fibrosis following myocardial infarction (MI). A, Real-time PCR analysis of miR-711 in myocar-
dium tissue (n=6) of MI rat. B, Real-time PCR analysis of miR-711 expression at different time (2, 7, 14 d) in rats following sham operation (n=6). Expres-
sion of miR-711 was standardized to 5s ribosomal RNA level. *, P<0.05 vs. sham; ***, P<0.001 vs. sham.  
Figure S2  miR-711 expression in cardiac fibroblasts stimulated by Ang II at different times. Cardiac fibroblasts were treated with Ang II (0.1 µmol) for up 
to 24 h and then miR-711 expression at different time points were detected. Real-time PCR analysis of expression of miR-711 standardized to 5s mRNA 
level. MiR-711 expression was not affected by Ang II. 
Figure S3  Using agomir to overexpress and antagomir to antagonize the expression of miR-711. Real-time PCR analysis of expression of miR-711 stand-
ardized to 5s mRNA level. 
Table S1  Real-time PCR primer sequences for amplification 
Table S2  The predicted conserved targets of miR-711 
The supporting information is available online at life.scichina.com and www.springerlink.com. The supporting materials 
are published as submitted, without typesetting or editing. The responsibility for scientific accuracy and content remains en-
tirely with the authors. 
 
 
